Rezende, G, Roque-Afonso, AM, Samuel, D, et al. Viral and clinical factors associated with the fulminant course of hepatitis A infection. Hepatology 2003;38:613–618.CrossRefGoogle ScholarPubMed

Robertson, BH, Jansen, RW, Khanna, B, et al. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 1992;73:1365–1377.CrossRefGoogle ScholarPubMed

Fujiwara, K, Yokosuka, O, Fukai, K, et al. Analysis of full-length hepatitis A virus genome in sera from patients with fulminant and self-limited acute type A hepatitis. J Hepatol 2001;35:112–119.CrossRefGoogle ScholarPubMed

Taylor, GM, Goldin, RD, Karayiannis, P, et al. In situ hybridization studies in hepatitis A infection. Hepatology 1992;16:642–648.CrossRefGoogle ScholarPubMed

Ticehurst, JR, Racaniello, VR, Baroudy, BM, et al. Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci USA 1983;80:5885–5889.CrossRefGoogle ScholarPubMed

Koff, RS. Hepatitis A. Lancet 1998;351:1643–1649.CrossRefGoogle ScholarPubMed

Craig, AS, Schaffner, W. Prevention of hepatitis A with the hepatitis A vaccine. N Engl J Med 2004;350:476–481.CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention. Hepatitis Surveillance Report 59. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2004:1–60.Google Scholar

Centers for Disease Control and Prevention. Hepatitits A outbreak associated with green onions at a restaurant – Monaca, Pennsylvania, 2003. MMWR Morb Mortal Wkly Rep 2003;52:1155–1157.Google Scholar

Wheeler, C, Vogt, TM, Armstrong, GL, et al. An outbreak of hepatitis A associated with green onions. N Engl J Med 2005;353:890–897.CrossRefGoogle ScholarPubMed

Hutin, YJF, Pool, V, Cramer, EH, et al. A multistate, foodborne outbreak of hepatitis A. N Engl J Med 1999;340:595–602.CrossRefGoogle ScholarPubMed

Weinberg, M, Hopkins, J, Farrington, L, et al. Hepatitis A in Hispanic children who live along the United States–Mexico border: the role of international travel and food-borne exposures. Pediatrics 2004;114:e68–73.CrossRefGoogle ScholarPubMed

Hadler, SC, Erben, JJ, Francis, DP, et al. Risk factors for hepatitis A in day-care centers, J Infect Dis 1982;145:255–261.CrossRefGoogle ScholarPubMed

Benenson, MW, Takafuji, ET, Bancroft, WH, et al. A military community outbreak of hepatitis type A related to transmission in a child care facility. Am J Epidemiol 1980;112:471–481.CrossRefGoogle Scholar

Vernon, AA, Schable, C, Francis, D. A large outbreak of hepatitis A in a daycare center: association with non-toilet-trained children and persistence of IgM antibody to hepatitis A virus. Am J Epidemiol 198;115:325–331.

Hadler, SC, Webster, HM, Erber, JJ, et al. Hepatitis A in day care centers: a community-wide assessment. N Engl J Med 1980;302:1222–1227.CrossRefGoogle ScholarPubMed

Balistreri, WF. Viral hepatitis. Emerg Clin North Am 1991;9:365–399.Google Scholar

Leach, C. Hepatitis A in the United States. Pediatr Infect Dis J 2004;23:551–552.CrossRefGoogle ScholarPubMed

Jung, YM, Park, SJ, Kim, JS et al. Atypical manifestations of hepatitis A infection: a prospective, multicenter study in Korea. J Med Virol. 2010;82:1318–1326.CrossRefGoogle ScholarPubMed

Rachima, CM, Cohen, E, Garty, M. Acute hepatitis A: combination of relapsing and the cholestatic forms, two rare variants. Am J Med Sci 2000;319:417–419.CrossRefGoogle ScholarPubMed

Schiff, ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992;10(Suppl 1):S18–S20.CrossRefGoogle ScholarPubMed

Ozcay, F, Canan, O, Akcan, B, et al. Hepatitis A super infection as a cause of liver failure in a child with Wilson’s disease. Turk J Pediatr 2007;49:199–202.Google Scholar

Ciocca, M, Moreira-Silva, SF, Alegria, S, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J 2007;26:711–715.CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48:1–39.Google Scholar

Kim, HY, Eyheramonho, MB, Pichavant, M, et al. A polymorphism in TIM1 is associated with susceptibility to severe hepatitis A virus infection in humans. J Clin Invest 2011;121:1111–1118.CrossRefGoogle ScholarPubMed

Arora, NK, Mathur, P, Ahuja, A, Oberoi, A. Acute liver failure. Indian J Pediatr 2003;70:73–79.CrossRefGoogle ScholarPubMed

Amon, JJ, Darling, N, Fiore, AE et al. Factors associated with hepatitis A vaccination among children 24 to 35 months of age: United States, 2003. Pediatrics 2006;117:30–33.CrossRefGoogle ScholarPubMed

Centers for Disease Control and Prevention. Vaccines and Immunizations. Atlanta, GA: Centers for Disease Control and Prevention, 2010 (, accessed 22 July 2013).Google Scholar

Centers for Disease Control and Prevention. Vaccine Recommendations of the Advisory Committee for Immunization Practices. Atlanta, GA: Centers for Disease Control and Prevention, 2013 (, accessed 22 July 2013).Google Scholar

Landry, P, Tremblay, S, Darioli, R, Genton, B. Inactivated hepatitis A vaccine booster given ≥24 months after the primary doses. Vaccine 2000;19:399–402.CrossRefGoogle Scholar

McMahon, BJ, Williams, J, Bulkow, L, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska native children and native and non-native adults. J Infect Dis 1995;17:676–679.CrossRefGoogle Scholar

Horng, YC, Chang, MH, Lee, CY, et al. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J 1993;12:359–362.CrossRefGoogle ScholarPubMed

Balcarek, KB, Bagley, MR, Pass, RF, Schiff, ER, Krause, DS. Safety and immunogenicity of an inactivated hepatitis A vaccine in preschool children. J Infect Dis 1995;171(Suppl 1):S70–S72.CrossRefGoogle ScholarPubMed

Ashur, Y, Adler, R, Rowe, M, Shouval, D. Comparison of immunogenicity of two hepatitis A vaccines – VAQTA and HAVRIX – in young adults. Vaccine 1999;17:2290–2296.CrossRefGoogle ScholarPubMed

Letson, GW, Shapiro, CN, Kuehn, D, et al. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. J Pediatr 2004;144:327–332.CrossRefGoogle ScholarPubMed

Das, A. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 1999;29:548–552.CrossRefGoogle ScholarPubMed

Werzberger, A, Mensch, B, Kuter, B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327:453–457.CrossRefGoogle ScholarPubMed

Innis, BL, Snithhan, R, Kunasol, P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328–1334.CrossRefGoogle ScholarPubMed

Gouvea, AF, De Moraes-pinto, MI, Ono, E, et al. Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children. Clin Infect Dis 2005;41:544–548.CrossRefGoogle ScholarPubMed

Siberry, GK, Coller, RJ, Henkle, E, et al. Antibody response to hepatitis A immunization among human immunodeficiency virus-infected children and adolescents. Pediatr Infect Dis J 2008;27:465–468.CrossRefGoogle ScholarPubMed

Weinberg, A, Gona, P, Nachman, SA, et al. Antibody-response to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active retroviral therapy. J Infect Dis 2006;193:302–311.CrossRefGoogle Scholar

Arslan, M, Wiesner, RH, Poterucha, JJ, Zein, NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001;72:272–276.CrossRefGoogle ScholarPubMed

Diana, A, Posfay-Barbe, KM, Belli, DC, Siegrist, CA. Vaccine-induced immunity in children after orthotopic liver transplantation: a 12-yr review of the Swiss national reference center. Pediatr Transplant 2007;11:31–37.CrossRefGoogle ScholarPubMed

Lee, SD, Chan, CY, Yu, MI, et al. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J Med Virol 1997;52:215–218.3.0.CO;2-J>CrossRefGoogle ScholarPubMed

Keeffe, EB, Iwarson, S, McMahon, BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998;27:881–886.CrossRefGoogle ScholarPubMed

Ferreira, CT, da Silviera, TR, Viera, SM et al. Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease. J Pediatr Gastroenterol Nutr 2003;37:258–261.CrossRefGoogle ScholarPubMed

El-Karaksy, HM, El-Hawary, MI, El-koofy, NM, et al. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease. World J Gastroenterol 2006;12:7337–7340.CrossRefGoogle ScholarPubMed

Majda-Stanislawska, E, Bednarek, M, Kuydowicz, J. Immunogenicity of inactivated hepatitis A vaccine in children with chronic liver disease. Pediatr Infect Dis J 2004;23:571–574.CrossRefGoogle ScholarPubMed

Troisi, CL, Hollinger, FB, Krause, DS, et al. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX®; SKB): a comparative study of two dosing schedules. Vaccine 1997;15:1613–1617.CrossRefGoogle Scholar

Piazza, M, Safary, A, Vegnente, A, et al. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine 1999;17:585–588.CrossRefGoogle ScholarPubMed

Dagan, R, Amir, J, Mijalovsky, A, et al. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibody. Pediatr Infect Dis J 2000;19:1045–1052.CrossRefGoogle ScholarPubMed

Fiore, AE, Shapiro, CN, Sabin, K, et al. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Pediatr Infect Dis J 2003;22:354–359.CrossRefGoogle ScholarPubMed

Hammitt, LL, Bulkow, L, Hennessy, TW, et al. Persistence of antibody to hepatitis A virus 10 years after vaccination among children and adults. J Infect Dis 2008;198:1776–1782.CrossRefGoogle ScholarPubMed

Werzberger, A, Mensch, B, Nalin, DR, Kuter, BJ. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years’ followup after the Monroe field trial of VAQTA. Vaccine 2002;20:1699–1701.CrossRefGoogle Scholar

Chang, CY, Lee, SD, Yu, MI, et al. Long-term follow-up of hepatitis A vaccination in children. Vaccine 1999;17:369–372.CrossRefGoogle Scholar

Van Damme, P, Banatvala, J, Fay, O, et al. Hepatitis A booster vacination: is there a need? Lancet 2003;362:1065–1071.CrossRefGoogle Scholar

Van Herckk, K, Van Damme, P. Inactivated hepatitis A vaccine-induced antibodies: follow-up and estimates of long-term persistence. J Med Virol 2001;63:1–7.3.0.CO;2-U>CrossRefGoogle Scholar

Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2006;55(RR-7):1–23.Google Scholar

Rosenthal, P. Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults. Hepatology 2003;37:44–51.CrossRefGoogle Scholar

Ansari, IH, Nanda, SK, Durgapal, H, et al. Cloning sequencing, and expression of the hepatitis E virus (HEV) nonstructural open reading frame 1. J Med Virol 2000;60:275–283.3.0.CO;2-9>CrossRefGoogle ScholarPubMed

Krawczynski, K, Aggarwal, R, Kamili, S. Infections of the liver. Infect Dis Clin N Am 2000;14:1–18.Google Scholar

Worm, HC, van der Poel, WHM, Brandstatter, G. Hepatitis E: an overview. Microbes Infect 2002;4:657–666.CrossRefGoogle ScholarPubMed

Aggarwal, R, Krawczynski, K. Hepatitis E: an overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 2000;15:9–20.CrossRefGoogle ScholarPubMed

Ahn, J-M, Kang, S-G, Lee, D-Y, et al. Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea. J Clin Microbiol 2005;3042–3048.CrossRefGoogle ScholarPubMed

Tam, AW, Smith, MM, Guerra, ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991;185:120–131.CrossRefGoogle ScholarPubMed

Reyes, GR, Purdy, MA, Kim, JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 1990;247:1335–1339.CrossRefGoogle ScholarPubMed

Shrestha, SM, Srestha, S, Tsuda, F, et al. Genetic changes in hepatitis E virus of subtype 1a in patients with sporadic acute hepatitis E in Kathmandu, Nepal, from 1997 to 2002. J Gen Virol 2004;85:97–104.CrossRefGoogle ScholarPubMed

Mansuy, JM, Peron, JM, Abravanel, F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004;74:419–424.CrossRefGoogle ScholarPubMed

Redlinger, T, O’Rourke, K, Nickey, L, Martinez, G. Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community. Tex Med 1998;94:68–71.Google Scholar

Aggarwal, R, Naik, SR. Faecal excretion of hepatitis-E virus. Lancet 1992;340:787.CrossRefGoogle ScholarPubMed

DeCock, KM, Bradley, DW, Sandford, NL, et al. Epidemic non-A, non-B hepatitis in patients from Pakistan. Ann Intern Med 1987;106:227–230.CrossRefGoogle Scholar

Ray, R, Aggarwal, R, Salunke, PN, et al. Hepatitis E virus genome in stools of hepatitis patients during large epidemic in North India, Lancet 1991;338:783–784.CrossRefGoogle ScholarPubMed

Skidmore, SJ, Yarbough, PO, Gabor, KA, et al. Hepatitis E virus: the cause of waterborne hepatitis outbreak. J Med Virol 1992;37:58–60.CrossRefGoogle Scholar

Ticehurst, J, Popkin, TJ, Bryan, JP, et al. Association of hepatitis E virus with an outbreak of hepatitis in Pakistan: serologic responses and pattern of virus excretion. J Med Virol 1992;36:84–92.CrossRefGoogle ScholarPubMed

Chauhan, A, Dilawari, JB, Jameel, S, et al. Common etiological agent for epidemic and sporadic non-A non-B hepatitis. Lancet 1992;339:1509–1510.CrossRefGoogle Scholar

Hau, CH, Hien, TT, Tien, NT, et al. Prevalence of enteric hepatitis A and E viruses in the Mekong delta region of Vietnam. Am J Trop Med Hyg 1998;60:277–280.CrossRefGoogle Scholar

Goto, K, Ito, K, Sugiura, T, et al. Prevalence of hepatitis E virus infection in Japanese children. J Pediatr Gastroenterol Nutr 2005;42:89–92.CrossRefGoogle Scholar

Emerson, SU, Purcell, RH. Running like water: the omnipresence of hepatitis E. N Engl J Med 2004;351:2367–2368.CrossRefGoogle ScholarPubMed

Bader, TF, Krawczynski, K, Polish, LB, et al. Hepatitis E in a US traveler to Mexico. N Engl J Med 1991;325:1659.Google Scholar

De Groen, PC. Hepatitis E in the United States: a case of “hog fever?”Mayo Clin Proc 1997;72:1197–1198.CrossRefGoogle ScholarPubMed

Goldsmith, R, Yarbough, PO, Reyes, GR, et al. Enzyme-linked immunosorbent assay for diagnosis of acute sporadic hepatitis E in Egyptian children. Lancet 1992;339:328–332.CrossRefGoogle ScholarPubMed

Hyams, KC, Purdy, MA, Kaur, M, et al. Acute sporadic hepatitis E in Sudanese children: analysis based on a new Western blot assay. J Infect Dis 1992;165:1001–1005.CrossRefGoogle ScholarPubMed

Daniel, HDJ, Warier, A, Abraham, P, Sridharan, G. Age-wise exposure rates to hepatitis E virus in a southern Indian patient population without liver disease. Am J Top Med Hyg 2004;71:675–678.Google Scholar

Khuroo, MS, Kamili, S, Yattoo, GN. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004;19:778–784.CrossRefGoogle Scholar

Singh, S, Mohanty, A, Joshi, YK, et al. Mother-to-child transmission of hepatitis E virus infection. Indian J Pediatr 2003;70:37–39, 597.CrossRefGoogle ScholarPubMed

Khuroo, MS, Kamili, S, Jameel, S. Vertical transmission of hepatitis E virus. Lancet 1995;345:1025–1026.CrossRefGoogle ScholarPubMed

Kumar, RM, Uduman, S, Rana, S, et al. Sero-prevalence and mother-to-infant transmission of hepatitis E virus among pregnant women in the United Arab Emirates. Eur J Obstet Gynecol Reprod Biol 2001;100:9–15.CrossRefGoogle ScholarPubMed

Arora, NK, Panda, SK, Nanda, SK, et al. Hepatitis E infection in children: study of an outbreak. J Gastroenterol Hepatol 1999;14:572–577.CrossRefGoogle ScholarPubMed

Worm, HC, van der Poel, WHM, Brandstatter, G. Hepatitis E: an overview. Microbes Infect 2002;4:657–666.CrossRefGoogle ScholarPubMed

Panda, SK, Jameel, S. Hepatitis E virus: from epidemiology to molecular biology. Viral Hepat 1997;3:227–251.Google Scholar

Kamar, N, Mansuy, JM, Cointault, O, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008;8:1744–1748.CrossRefGoogle ScholarPubMed

Kamar, N, Garrouste, C, Haagsma, EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481–1489.CrossRefGoogle ScholarPubMed

Hamid, SS, Atiq, M, Shehzad, F, et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology 2002;36:474–478.CrossRefGoogle ScholarPubMed

Kumar, A, Aggarwal, R, Naik, SR, et al. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol 2004;23:59–62.Google Scholar

Ramachandran, J, Eapen, CE, Kang, G, et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol 2004;19:134–138.CrossRefGoogle ScholarPubMed

Davern, TJ, Chalasani, N, Fontana, RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011;14:1665–1672.CrossRefGoogle Scholar

Bile, K, Isse, A, Mohamud, O, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994;51:466–474.CrossRefGoogle Scholar

Corwin, AL, Khiem, HB, Clayson, ET, et al. A waterborne outbreak of hepatitis E virus transmission in southwestern Vietnam. Am J Trop Med Hyg 1996;54:559–562.CrossRefGoogle ScholarPubMed

Khuroo, MS, Dar, MY. Hepatitis E: Evidence for person-to-person transmission and inability of low dose immune serum globulin from an Indian source to prevent it. Indian J Gastroenterol 1992;3:113–116.Google Scholar

Tsarev, SA, Tsareva, TS, Emerson, SU, et al. Successful passive and active immunization of cynomolgus monkeys against hepatitis E. Proc Natl Acad Sci USA 1994;91:10198–10202.CrossRefGoogle ScholarPubMed

Tsarev, SA, Tsareva, TS, Emerson, SU, et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. Vaccine 1997;15:1834–1838.CrossRefGoogle ScholarPubMed

Kamili, S. Toward the development of a hepatitis E vaccine. Virus Res 2011;161:93–100.CrossRefGoogle ScholarPubMed

Alric, L, Bonnet, D, Laurent, G, et al. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010;153:135–136.CrossRefGoogle Scholar

Kamar, N, Rostaing, L, Abravanel, F, et al. Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection. Gastroenterology 2010;139:1612–1618.CrossRefGoogle ScholarPubMed